- Home
- TBI vs ANIK Comparison
TBI vs ANIK Comparison
Compare TBI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TBI
- ANIK
- Stock Information
- Founded
- TBI 1985
- ANIK 1983
- Country
- TBI United States
- ANIK United States
- Employees
- TBI N/A
- ANIK N/A
- Industry
- TBI Professional Services
- ANIK Medical/Dental Instruments
- Sector
- TBI Consumer Discretionary
- ANIK Health Care
- Exchange
- TBI Nasdaq
- ANIK Nasdaq
- Market Cap
- TBI 169.0M
- ANIK 196.6M
- IPO Year
- TBI 1996
- ANIK 1993
- Fundamental
- Price
- TBI $6.95
- ANIK $10.68
- Analyst Decision
- TBI Buy
- ANIK Buy
- Analyst Count
- TBI 1
- ANIK 1
- Target Price
- TBI $10.00
- ANIK $19.00
- AVG Volume (30 Days)
- TBI 222.0K
- ANIK 55.6K
- Earning Date
- TBI 08-04-2025
- ANIK 08-07-2025
- Dividend Yield
- TBI N/A
- ANIK N/A
- EPS Growth
- TBI N/A
- ANIK N/A
- EPS
- TBI N/A
- ANIK N/A
- Revenue
- TBI $1,534,794,000.00
- ANIK $117,053,000.00
- Revenue This Year
- TBI $0.80
- ANIK N/A
- Revenue Next Year
- TBI $6.90
- ANIK $9.70
- P/E Ratio
- TBI N/A
- ANIK N/A
- Revenue Growth
- TBI N/A
- ANIK 4.61
- 52 Week Low
- TBI $3.45
- ANIK $10.65
- 52 Week High
- TBI $12.29
- ANIK $29.12
- Technical
- Relative Strength Index (RSI)
- TBI 68.79
- ANIK 43.24
- Support Level
- TBI $6.08
- ANIK $10.85
- Resistance Level
- TBI $7.35
- ANIK $11.34
- Average True Range (ATR)
- TBI 0.36
- ANIK 0.35
- MACD
- TBI 0.05
- ANIK 0.09
- Stochastic Oscillator
- TBI 85.50
- ANIK 44.63
About TBI TrueBlue Inc.
TrueBlue Inc is a provider of staffing and workforce management solutions. Its reportable segments include PeopleReady offers industrial staffing services. PeopleManagement offers contingent and productivity-based on-site industrial staffing services and PeopleScout offers recruitment process outsourcing, talent advisory services, and managed service provider services. It generates maximum revenue from the PeopleReady segment.
About ANIK Anika Therapeutics Inc.
Anika Therapeutics Inc is an orthopedic medicines company. It is committed to improving the lives of patients with degenerative orthopedic diseases and traumatic conditions with clinically meaningful therapies. The company focuses on orthopedics, including osteoarthritis pain management, regenerative solutions, soft tissue repair, and bone preserving joint technologies. Geographically, it derives a majority of its revenue from the United States and also has its presence in Europe and Other countries.